| 000 | 01624 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515120255.0 | ||
| 264 | 0 | _c20080709 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a1464-3405 | ||
| 024 | 7 |
_a10.1016/j.bmcl.2008.04.028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPfefferkorn, Jeffrey A | |
| 245 | 0 | 0 |
_aP2Y1 receptor antagonists as novel antithrombotic agents. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cJun 2008 |
||
| 300 |
_a3338-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine Diphosphate _xpharmacology |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aCombinatorial Chemistry Techniques |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Antagonists |
| 650 | 0 | 4 | _aReceptors, Purinergic P2Y1 |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aChoi, Chulho | |
| 700 | 1 | _aWinters, Thomas | |
| 700 | 1 | _aKennedy, Robert | |
| 700 | 1 | _aChi, Liguo | |
| 700 | 1 | _aPerrin, Lisa A | |
| 700 | 1 | _aLu, Gina | |
| 700 | 1 | _aPing, Yun-Wen | |
| 700 | 1 | _aMcClanahan, Tom | |
| 700 | 1 | _aSchroeder, Richard | |
| 700 | 1 | _aLeininger, Michael T | |
| 700 | 1 | _aGeyer, Andrew | |
| 700 | 1 | _aSchefzick, Sabine | |
| 700 | 1 | _aAtherton, James | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 18 _gno. 11 _gp. 3338-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2008.04.028 _zAvailable from publisher's website |
| 999 |
_c17941995 _d17941995 |
||